In the in vivo study, the NASH mice were treated with adenovirus Lv-Anxa2 for overexpressing Anxa2. Then, the mice with overexpressed Anxa2 were administrated with VX-765 (inhibitor for Caspase-1). The gene discussed is CASP1; the disease is metabolic dysfunction-associated steatohepatitis.